Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blake C Beehler

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|December 3, 2004
Selective retinoic acid receptor ligands for rheumatoid arthritisBlake C Beehler, Constance E Brinckerhoff, Jacek Ostrowski
Experimental Biology and Medicine (Maywood, N.J.)|March 4, 2006
Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervationBlake C Beehler, Paul G Sleph, Latifa Benmassaoud, et al.
Development (Cambridge, England)|August 6, 2004
Retinoic acid signalling specifies intermediate character in the developing telencephalonMatthew Marklund, My Sjödal, Blake C Beehler, et al.
Endocrinology|January 1, 2004
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronineGary J Grover, Donald M Egan, Paul G Sleph, et al.
The Journal of Rheumatology|February 4, 2003
Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritisBlake C Beehler, Yong-Jiang Hei, Simon Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulatorsMark C Manfredi, Yingzhi Bi, Alexandra A Nirschl, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
Journal of Medicinal Chemistry|June 8, 2007
Discovery of potent and muscle selective androgen receptor modulators through scaffold modificationsJames J Li, James C Sutton, Alexandra Nirschl, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|December 3, 2004
Selective retinoic acid receptor ligands for rheumatoid arthritisBlake C Beehler, Constance E Brinckerhoff, Jacek Ostrowski
Experimental Biology and Medicine (Maywood, N.J.)|March 4, 2006
Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervationBlake C Beehler, Paul G Sleph, Latifa Benmassaoud, et al.
Development (Cambridge, England)|August 6, 2004
Retinoic acid signalling specifies intermediate character in the developing telencephalonMatthew Marklund, My Sjödal, Blake C Beehler, et al.
Endocrinology|January 1, 2004
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronineGary J Grover, Donald M Egan, Paul G Sleph, et al.
The Journal of Rheumatology|February 4, 2003
Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritisBlake C Beehler, Yong-Jiang Hei, Simon Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulatorsMark C Manfredi, Yingzhi Bi, Alexandra A Nirschl, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
Journal of Medicinal Chemistry|June 8, 2007
Discovery of potent and muscle selective androgen receptor modulators through scaffold modificationsJames J Li, James C Sutton, Alexandra Nirschl, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Pageof 1